alpha-aminopyridine has been researched along with Sjogren's Syndrome in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Asashima, H; Hirota, T; Iizuka-Koga, M; Kondo, Y; Matsui, M; Matsumoto, I; Segawa, S; Sumida, T; Tahara, M; Takahashi, H; Tsuboi, H | 1 |
1 other study(ies) available for alpha-aminopyridine and Sjogren's Syndrome
Article | Year |
---|---|
RORγt antagonist suppresses M3 muscarinic acetylcholine receptor-induced Sjögren's syndrome-like sialadenitis.
Topics: Adoptive Transfer; Aminopyridines; Animals; Cells, Cultured; Disease Models, Animal; Enzyme Inhibitors; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Nuclear Receptor Subfamily 1, Group F, Member 3; Peptide Fragments; Receptor, Muscarinic M3; Sialadenitis; Sjogren's Syndrome; Sulfonamides; Th1 Cells; Th17 Cells | 2017 |